CTT PHARMACEUTICAL HOLDINGS, INC. purchased $479 of CTTH
CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 9,800 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.05 on 2026-09-04.
How this was made
The 30-second read
Why it matters
The purchase is modest and unlikely to move the stock price.
Market read
Limited relevance; primarily of interest to insiders and compliance monitors.
What to watch
Potential future insider activity if CEO continues buying.
Background
Form 4 filing discloses insider transactions; this is the first public report of the purchase.
Ticker impact
CEO purchased 9,800 shares for $479, increasing holdings to 9,397,056 shares.
Minimal upward pressure, likely negligible.
The transaction size is tiny relative to total shares outstanding, so market reaction is expected to be muted.
Market effects
None significant for pharmaceutical sector.
No regional effect.
Not globally relevant.
Counterpoint
Insider purchase could signal confidence, but size is too small to matter.
Key entities
- CompanyCTT Pharmaceutical Holdings, Inc.
Issuer of the Form 4 filing.
- IndividualCEO (unnamed)
Insider executing the purchase.